| Filed On | Filing |
|---|---|
| 06 Nov 2020 |
Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others
Holds 9,111,848 shares of Ordinary shares |
| 03 Feb 2020 |
Form 3: Altschuler Steven, Director
No securities owned |
| 02 Jan 2020 |
Form 3: Fmr Llc, 10% owner
Holds 6,136,532 shares of Ordinary shares |
| 02 Jan 2020 |
Form 3: Thomas Frank E, See Remarks
Holds 15,120 shares of Ordinary Shares |
| 02 Jan 2020 | Form 3: Secor Alicia, Director |
| 02 Jan 2020 |
Form 3: Rowland Charles A Jr, Director
Holds 12,294 shares of Ordinary Shares |
| 02 Jan 2020 |
Form 3: Rothera Mark, Director
Holds 93,796 shares of Ordinary Shares |
| 02 Jan 2020 |
Form 3: Geraghty James A, Director
Holds 44,391 shares of Ordinary Shares |
| 02 Jan 2020 |
Form 3: Gaspar Bobby, Director
Holds 348,319 shares of Ordinary Shares |
| 02 Jan 2020 |
Form 3: Ellis Jon, Director
No securities owned |
| 02 Jan 2020 |
Form 3: Dunoyer Marc, Director
Holds 37,179 shares of Ordinary Shares |
| 02 Jan 2020 | Form 3: Curnutte John T, Director |
| 02 Jan 2020 |
Form 3: Beck Joanne T., Director
Holds 9,294 shares of Ordinary Shares |
| 02 Jan 2020 |
Form 3: Glaxosmithkline Plc, Director
Holds 12,455,252 shares of Ordinary Shares, nominal value (GBP)0.10 per share |
Loading...